HCPCS Level II
J7677
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
Codes near J7677
These sit next to J7677 in the CMS Level II file. All J codes
- J7668Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams
- J7669Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams
- J7670Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams
- J7674Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg
- J7676Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg
- J7680Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7681Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7682Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
- J7683Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7684Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 49502-0806-93 | Yupelri | Viatris Specialty LLC | 5250 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.